Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor. Wichmann J, Rynn C, Friess T, Petrig-Schaffland J, et al. Clin Cancer Res 2022;28:770-780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wichmann J, Rynn C, Friess T, Petrig-Schaffland J, et al. Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor. Clin Cancer Res 2022;28:770-780.
PMID: 34782366